Not following you -- why would ARTH's problem hurt
Post# of 72440
haha remember that Mako attempted to use NNVC to tarnish CTIX -- even though Leo Ehrlich has had nothing to do with NNVC for years and stated that the only time he had communicated with any of them for years was when he said hello at a conference. Pretty evident that they parted on less than amicable terms.
I think I'm correct in saying that none of Patrick Cox's picks in his thousand-dollar-a-year newsletter have gotten a drug to a successful clinical trial, except CTIX. Could be wrong, I'm not and never have been a subscriber so I don't know what all of his picks are.